Clin2
NCT07235215Possibly a fitRecruiting

Testing Vivatlac for Irritable Bowel Syndrome

Irritable Bowel Syndrome

Part of Digestive system clinical trials.

This study tests a product called Vivatlac to see if it can help people with Irritable Bowel Syndrome (IBS). If you have moderate-to-severe IBS and haven't taken probiotics or antibiotics recently, you may be able to join.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
200 people
Ages
18 years to 65 years
Study type
Interventional

Who can take part

  • You have been diagnosed with Irritable Bowel Syndrome (IBS) by a doctor
  • Your IBS symptoms are moderate to severe (a symptom score of 175 or higher)
  • You haven't taken probiotics or antibiotics in the past 3 months
  • You don't have other serious health conditions like cancer, uncontrolled high blood pressure, or liver/kidney disease
  • You don't have other bowel diseases like Crohn's, colitis, or celiac disease
  • You are not pregnant, breastfeeding, or planning to become pregnant in the next 9 months

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07235228Recruiting
Synbiotic supplement for irritable bowel syndrome

This trial tests whether a synbiotic (a mix of probiotics and prebiotics) called Vivatlac can improve gut health in people with moderate to severe irritable bowel syndrome (IBS). If you have IBS and are not already taking probiotics or antibiotics, you may be able to join.

Jarocin
NCT05100719Not yet recruiting
Lactose intolerance and irritable bowel syndrome study

This study looks at how lactose intolerance relates to irritable bowel syndrome (IBS) in people who already have both. It may help doctors understand the link and improve treatment. Participants will have their lactose digestion checked with special breath tests.

Pécs
NCT06433180Not yet recruiting· Phase 3
Fecal transplant for severe irritable bowel syndrome

This trial tests whether a fecal microbiota transplantation (FMT), which transfers healthy bacteria from a donor into your gut, can reduce severe irritable bowel syndrome (IBS) symptoms. FMT is being studied as a possible new treatment for people with IBS that hasn't improved with other treatments.

Bobigny
NCT06636513Recruiting
Testing SMT04 for irritable bowel syndrome

This trial tests a new treatment called SMT04 for people with irritable bowel syndrome (IBS), specifically the diarrhea or mixed types. It may help reduce symptoms like abdominal pain and changes in bowel habits.

Singapore, Singapore
NCT07039747Recruiting· Phase 2
Can a dietary supplement help people with irritable bowel syndrome?

This trial is testing if a dietary supplement can reduce symptoms of irritable bowel syndrome (IBS). You might qualify if you have been diagnosed with IBS, have moderate to severe symptoms, and are between 18 and 75 years old.

Rouen, France
NCT07716852Not yet recruiting
Testing a probiotic supplement for irritable bowel syndrome

This study tests a dietary supplement called Enzymax DuoBiotics to see if it helps ease irritable bowel syndrome (IBS) symptoms like belly pain and irregular bowel habits. If you have IBS and are looking for a non-drug option, this may be a good fit.

Hear when a new Irritable Bowel Syndrome trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.